Rehabiliation Using HUBER 360 to Reduce the Risk of Falls

Not Applicable

Completed

• Conditions: Treatment Outcome; Quality of Life; Fall; Rehabilitation; Exercise Therapy
• Interventions: Device: HUBER (LPG Systems, France)

• Registration Number: NCT04687293
• Lead Sponsor: University of Liege

Brief Summary

Aim: The aim of the present study was to analyse the effects of training performed on a rotating, motorised platform (the Huber/SpineForce device from LPG Systems, Valence, France) intended to reduce the risk of falls.

Subjects: any patient 1) benefiting from a physiotherapy rehabilitation program at the CHU Liège, CNRF, Belgium; 2) presenting a pathological situation justifying functional rehabilitation with HUBER 360®; 3) presenting any pathology not constituting an exclusion criterion; 4) giving informed consent to research will be include in this 8-week interventional trial.

Design: randomized open-label trial. Patients will be randomized into the intervention group (HUBER trainig, 45 minutes of training, twice a week during 8 weeks) or in the control group (standard care).

Outcomes: the effect of the training will be measured on the Time-Up-and-Go test, on the Short-Physical performance battery test and on quality of life.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-12-09
• Study First Submitted: 2020-12-09
• Study First Submitted QC: 2020-12-22
• Study First Posted: 2020-12-29
• Primary Completion: 2022-11-02
• Study Completion: 2022-11-02
• Status Verified: 2023-05
• Last Update Submitted: 2023-05-11
• Last Update Posted: 2023-05-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• Patient benefiting from a physiotherapy rehabilitation program at the CHU Liège, CNRF
• Patient presenting a pathological situation justifying functional rehabilitation with HUBER 360®
• Patient presenting any pathology not constituting an exclusion criterion
• Patient giving informed consent to research.

Exclusion Criteria

• Cardiac or respiratory or neurological or rheumatological disease incompatible with physical activity ;
• Joint inflammation;
• Rheumatic disease in acute phase;
• Recent trauma, infection of the musculoskeletal system;
• Fever;
• Venous thrombosis ;
• Discopathy in acute phase;
• Neuropsychological problems that do not allow to integrate the instructions or other serious psychological problems;
• Cardiovascular diseases and any progressive, chronic, counter-indicative disease;
• Large anatomical deformities.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
HUBER	HUBER (LPG Systems, France)	HUBER is an isometric strengthening device. It consists of an oval motorized platform, which performs rotating, oscillatory movements with a controlled amplitude and speed. Intervention will consist of 2 sessions of HUBER per week. Each session lasts approximatively 30 minutes. The intervention is 8 weeks long.

Primary Outcome Measures

Name	Time	Method
Risk of falls, in seconds	8 weeks	Measured with Timed-Up-and Go test

Secondary Outcome Measures

Name	Time	Method
Quality of life, measured with the Short Form-36 questionnaire	8 weeks	SF-36 generic quality of life questionnaire. The score obtained from this questionnaire is composed with a Physcial component Scale (PMS) and a Mental component scale (MCS). Results are scored from 0 (worst quality of life) to 100 (best quality of life).
Physical performance	8 weeks	Short Physical Performance Battery test (SPPB test). The test is scored from 0 (lower physical performance) to 12 (highest physical performance)
Utility score using the EuroQol- 5 Dimension questionnaire	8 weeks	Descriptive data from the 5 dimensions can be used to generate a health-related quality of life profile for the subject. The questionnaire is scored from 0 (worst health state imaginable) to 100 (best health state imaginable).

Trial Locations

Locations (1)

CHU Liège, CNRF; 🇧🇪 Tinlot, Liège, Belgium